Nu Skin Enterprises, Inc.

NYSE:NUS Stok Raporu

Piyasa değeri: US$341.5m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Nu Skin Enterprises Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Nu Skin Enterprises şirketinin toplam hissedar öz sermayesi $686.2M ve toplam borcu $458.3M olup, bu da borç-öz sermaye oranını 66.8% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $1.6B ve $899.8M dir. Nu Skin Enterprises 'in FAVÖK'ü $105.2M faiz karşılama oranı 3.7 dur. Şirketin $242.4M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

66.8%

Borç/özkaynak oranı

US$458.33m

Borç

Faiz karşılama oranı3.7x
NakitUS$242.36m
EşitlikUS$686.16m
Toplam yükümlülüklerUS$899.81m
Toplam varlıklarUS$1.59b

Son finansal sağlık güncellemeleri

Recent updates

Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business

Aug 31
Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business

Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price

Aug 13
Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price

Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

May 30
Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?

May 13
Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?

Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal

Mar 28
Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal

Nu Skin: A Sell Signal Amidst Industry Decline And Strategic Uncertainty

Mar 04

We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings

Feb 22
We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings

Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06

Feb 19
Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06

Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically

Feb 18
Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically

Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks

Jan 18
Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks

Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet

Dec 14
Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet

Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39

Nov 17
Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39

Nu Skin: Is It Just A Growth Problem?

Oct 17

Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

Oct 09
Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?

Sep 27
When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?

Nu Skin: Attractive Valuation Trumps Near-Term Risks

Sep 12

Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt

Sep 08
Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt

Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39

Aug 05
Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39

Is Nu Skin Enterprises, Inc. (NYSE:NUS) Expensive For A Reason? A Look At Its Intrinsic Value

Jul 31
Is Nu Skin Enterprises, Inc. (NYSE:NUS) Expensive For A Reason? A Look At Its Intrinsic Value

Nu Skin: A High-Risk/High-Reward Turnaround Play Worth The Risks

Jun 26

Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?

Jun 23
Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?

We Think Nu Skin Enterprises (NYSE:NUS) Is Taking Some Risk With Its Debt

May 22
We Think Nu Skin Enterprises (NYSE:NUS) Is Taking Some Risk With Its Debt

Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.39

May 07
Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.39

Nu Skin Enterprises (NYSE:NUS) Could Be Struggling To Allocate Capital

Apr 26
Nu Skin Enterprises (NYSE:NUS) Could Be Struggling To Allocate Capital

Why Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Worth Watching

Mar 18
Why Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Worth Watching

Nu Skin Enterprises (NYSE:NUS) Will Pay A Larger Dividend Than Last Year At $0.39

Feb 19
Nu Skin Enterprises (NYSE:NUS) Will Pay A Larger Dividend Than Last Year At $0.39

Nu Skin raises quarterly dividend by 1.3% to $0.39/share

Feb 15

These 4 Measures Indicate That Nu Skin Enterprises (NYSE:NUS) Is Using Debt Reasonably Well

Feb 12
These 4 Measures Indicate That Nu Skin Enterprises (NYSE:NUS) Is Using Debt Reasonably Well

Returns On Capital At Nu Skin Enterprises (NYSE:NUS) Paint A Concerning Picture

Jan 25
Returns On Capital At Nu Skin Enterprises (NYSE:NUS) Paint A Concerning Picture

Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?

Dec 04
Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?

Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.385

Nov 17
Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.385

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: NUS 'nin kısa vadeli varlıkları ( $654.4M ) kısa vadeli yükümlülüklerini ( $308.6M ) aşıyor.

Uzun Vadeli Yükümlülükler: NUS şirketinin kısa vadeli varlıkları ( $654.4M ) uzun vadeli yükümlülüklerini ( $591.2M ) aşmaktadır.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: NUS 'nin net borç/öz sermaye oranı ( 31.5% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: NUS şirketinin borç/öz sermaye oranı son 5 yılda 48.9% seviyesinden 66.8% seviyesine yükseldi.

Borç Kapsamı: NUS 'nin borcu işletme nakit akışı ( 34.8% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: NUS 'in borcuna ilişkin faiz ödemeleri EBIT ( 3.7 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.


Bilanço


Sağlıklı şirketleri keşfedin